NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-075-2002-0-US-01 Material and Method for Determining Absolute Clonal Frequency For A T Cell Clone US 60/373,420 Abandoned
NIMH E-203-2001-0-EA-04 Methods for Treating Prion Disease in Animals EA National Stage 200301127 Expired
NIMH E-203-2001-0-AU-06 Methods for Treating Prion Disease in Animals AU National Stage 2002256228 Abandoned
NIMH E-203-2001-0-CA-05 Methods for Treating Prion Disease in Mammals CA National Stage 2443900 Abandoned
NCI E-257-2001-0-PCT-02 SOCS-1 Gene Methylation in Cancer PCT PCT PCT/US2002/011790 Expired
NCI E-103-2002-0-US-01 p-Toluenesulfonhydrazide Derivazation for Separation and Measurement of Endogenous Estrogen Metabolites by High-Performance Liquid... US 60/372,848 Abandoned
NCI E-153-1998-0-US-03 CDK4 BINDING PEPTIDE US National Stage 10/018,964 7256256 Abandoned PDF
NINDS E-082-1997-1-US-01 USE OF MARROW-DERIVED GLIAL PROGENITORS CELLS AS GENE DELIVERY VECHICLES INTO THE CENTRAL NERVOUS SYSTEM US CIP 10/122,703 7022321 Abandoned PDF
NIA E-146-1993-0-US-05 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 10/121,500 6500859 Expired PDF
NIMH E-098-2001-0-PCT-02 Modified Random Primers For Probe Labeling PCT PCT PCT/US02/11656 Expired
NIMH E-098-2001-0-EP-05 Amine Modified Random Primers For Microarray Detection EP National Stage 02723843.5 Abandoned
NCI E-257-1999-0-US-06 METHOD AND COMPOSITIONS FOR CORRELATING CCR5 EXPRESSION WITH ESSENTIAL HYPERTENSION US National Stage 10/110,519 Abandoned
NIMH E-098-2001-0-CA-04 Amine Modified Random Primers For Microarray Detection CA National Stage 2443894 Abandoned
NIMH E-098-2001-0-AU-06 Amine Modified Random Primers For Microarray Detection AU National Stage 2002254606 Abandoned
NIAID E-355-2001-0-US-01 VAC-BAC Shuttle Vector System US 60/371,840 Abandoned
NICHD E-209-2001-1-US-01 NEUROTROPHIC COMPONENTS OF THE ADNF 1 COMPLEX US 60/371,961 Abandoned
NCI E-076-1997-1-US-02 Substitued Benzimidazoles as Non-Nucleoside Inhibitors of Reverse Transcriptase US CON 10/119,634 6894068 Abandoned PDF
NIAMS E-067-2001-0-PCT-02 Synthesis and Secretion of Native Recombinant Lysomal Enzymes By Liver PCT PCT PCT/US02/011119 Expired
NCI E-152-2002-0-US-01 QUANTITATIVE ASSAY OF THE ANGIOGENIC AND ANTIANGIOGENIC ACTIVITY OF A TEST MOLECULE. US 60/371,010 Abandoned
NICHD E-248-1998-0-US-08 Precision Laser Capture Microdissection Utilizing Short Pulse Length US CON 10/118,487 6897038 Expired PDF
NIDDK E-146-2001-0-PCT-02 INHIBITORS OF ACYL GLUCOSAMINYL INOSITOL AMIDASE AND METHODS OF USE PCT PCT PCT/US2002/011117 Expired
NCI E-253-2000-0-PCT-02 Artificial Chromosomes That Can Shuttle Between Bacteria, Yeast, And Mammalian Cells PCT PCT PCT/US02/10990 Abandoned
NCI E-253-2000-0-US-03 Artificial Chromosomes That Can Shuttle Between Bacteria, Yeast, And Mammalian Cells US National Stage 10/474,070 Abandoned
CC E-207-2001-1-US-01 Biopsy Needle With Radio Frequency Cauterization US 60/370,965 Abandoned
NHGRI E-306-2001-0-US-01 CELL-BASED GENE SILENCING MICROARRAYS AND METHODS OF THEIR USE US 60/370,970 Abandoned
NIDDK E-146-2001-0-CN-04 No_Patent_Title CN National Stage 02811333.0 Abandoned
NIMH E-281-1999-0-US-03 Tyrosine-DNA Phosphodiestrerases(TDP) and Related Polypeptides, Nucleic Acids, Vectors, TDP-Producing Host Cells, Antibodies and Methods of Use US National Stage 10/110,176 7087736 Abandoned PDF
NCI E-194-1998-0-US-03 Calcium Channel Proteins US DIV 10/116,949 6979724 Abandoned PDF
NCI E-060-2002-1-US-01 DNA Binding Polyamide Drug Conjugates US 60/370,168 Abandoned
NCI E-125-2002-0-US-01 METHODS OF DIAGNOSING PROTENTIAL FOR DEVELOPING HEPATOCELLULAR CARCINOMA OR METASTASIS AND IDENTIFYING THERAPEUTIC TARGETS US 60/370,895 Abandoned
NCI E-199-2002-0-US-01 Treatment Method of Kidney Cancer US 60/369,868 Abandoned
NHLBI E-148-2001-0-US-01 METHOD AND APPARATUS FOR COUNTERCURRENT CHROMATOGRAPHY US 60/370,641 Abandoned
NCI E-057-2002-1-US-01 Conjugates of Ligand, Linker and Cytotoxic Agents and Related Composition And Methods of Use US 60/370,189 Abandoned
NCI E-090-2001-0-ZA-07 Retroviral Protease Inhibiting Compound and Methods of Preparation, Pharmaceutical Compositions and Methods of Treating Viral Infections ZA National Stage ZA 200202655 Expired
NCI E-172-2000-0-PCT-02 Nucleic Acids For Transgene Expression PCT PCT PCT/US02/10594 Abandoned
NCI E-138-2001-0-PCT-02 Use of Semenogelin in the Diagnosis, Prognosis And Treatment of Cancer PCT PCT PCT/US02/10535 Expired
NICHD E-069-2000-3-CA-01 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... CA National Stage 2412864 Abandoned
NICHD E-069-2000-3-DK-13 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... DK EP 02728620.2 Abandoned
NICHD E-069-2000-3-LU-15 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... LU EP 02728620.2 Abandoned
NICHD E-069-2000-3-GB-11 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... GB EP 02728620.2 Abandoned
NICHD E-069-2000-3-SE-17 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... SE EP 02728620.2 Abandoned
NICHD E-069-2000-3-CH-08 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... CH EP 02728620.2 Abandoned
NICHD E-069-2000-3-DE-09 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... DE EP 02728620.2 Abandoned
NICHD E-069-2000-3-FR-10 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... FR EP 02728620.2 Abandoned
NICHD E-069-2000-3-ES-14 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... ES EP 02728620.2 Abandoned
NICHD E-069-2000-3-NL-16 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... NL EP 02728620.2 Abandoned
NICHD E-069-2000-3-IT-12 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... IT EP 02728620.2 Abandoned
NICHD E-069-2000-3-AT-06 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... AT EP 02728620.2 Abandoned
NICHD E-069-2000-3-BE-07 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... BE EP 02728620.2 Abandoned
NICHD E-069-2000-3-EP-03 METHODS OF MAKING, USING AND PHARMACEUTICAL FORMULATIONS COMPRISING 7 ALPHA, 11BETA-DIMETHYL-17BETA-HYDROXYLATIONS-4,14 DIEN-3-ONE AND 17... EP National Stage 02728620.2 Abandoned